Veradermics (NYSE:MANE) Price Target Raised to $164.00

Veradermics (NYSE:MANE) had its price objective boosted by equities research analysts at Needham & Company LLC from $136.00 to $164.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Needham & Company LLC’s price objective suggests a potential upside of 28.62% from the stock’s previous close.

Several other research analysts have also recently weighed in on the company. B. Riley Financial began coverage on Veradermics in a report on Wednesday. They set a “buy” rating and a $170.00 target price on the stock. Leerink Partners lifted their price objective on Veradermics from $75.00 to $90.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 22nd. Wall Street Zen lowered Veradermics from a “hold” rating to a “sell” rating in a research note on Sunday. Jefferies Financial Group upped their target price on Veradermics from $138.00 to $182.00 and gave the company a “buy” rating in a report on Tuesday, July 7th. Finally, Lifesci Capital began coverage on Veradermics in a research note on Tuesday, June 16th. They issued an “outperform” rating and a $135.00 target price for the company. Seven analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $149.43.

Veradermics Price Performance

Shares of Veradermics stock traded up $17.34 during trading hours on Wednesday, reaching $127.51. 738,182 shares of the company’s stock were exchanged, compared to its average volume of 548,542. Veradermics has a 1 year low of $32.00 and a 1 year high of $131.24. The stock has a market capitalization of $5.33 billion and a P/E ratio of -97.38. The firm has a fifty day moving average price of $106.54.

Veradermics (NYSE:MANE) last posted its quarterly earnings results on Tuesday, May 12th. The company reported ($1.32) earnings per share for the quarter, missing the consensus estimate of ($0.56) by ($0.76).

Veradermics Company Profile

MANE is a global manufacturer and supplier of flavors, fragrances and ingredients for the food, beverage, personal care, household and fine fragrance markets. Headquartered in France, the company develops and produces aromatic solutions that are used by consumer goods companies, food processors, perfumers and formulators seeking sensory impact, taste modulation and olfactory character for their products.

The company’s product portfolio includes savory and sweet flavor systems, beverage concentrates, natural extracts, essential oils, fragrance compounds, cosmetic ingredients and specialty functional solutions such as taste enhancers and odor masking agents.